SFCM
CGON icon

Seven Fleet Capital Management’s CG Oncology CGON Stock Holding History

Seven Fleet Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134M Buy
1,886,236
+1,810,478
+2,390% +$118M 22.12% 1
2026
Q1 		$5.13M Sell
75,758
-1,439,393
-95% -$81.6M 1.61% 14
2025
Q4 		$62.9M Buy
+1,515,151
New +$62.7M 42.57% 1

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Seven Fleet Capital Management's CGON Position: Q2 2026 in Review

Seven Fleet Capital Management increased its CG Oncology (CGON) stake by 2,390% in Q2 2026, buying an estimated $118M and bringing the position to 1,886,236 shares worth $134M. The position accounts for 22.12% of the portfolio, ranked #1.

Seven Fleet Capital Management first reported a position in CGON in Q4 2025 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Seven Fleet Capital Management held 1,886,236 shares of CG Oncology worth $134M as of Q2 2026.
  • Seven Fleet Capital Management bought 1,810,478 CG Oncology shares in Q2 2026, an estimated $118M.
  • CG Oncology made up 22.12% of Seven Fleet Capital Management's portfolio in Q2 2026, its #1 holding.
  • Seven Fleet Capital Management first reported a position in CG Oncology in Q4 2025 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.